mardi 19 avril 2016

Onco Actu du 19 avril 2016

1. Biologie

Circulating Tumor Cells Traverse Tiny Vasculature [The Scientist]

3.3 Prévention - Vaccins

Switching to newest HPV vaccine can save billions in health care costs, study says [STAT]

5.12 Immunothérapies

Cancer MoonShot 2020 Forms Radiation and Immuno-Oncology Working Group to Accelerate Efforts to Win the War on Cancer [National Immunotherapy Coalition]

5.2 Pharma

Merck Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Classical Hodgkin Lymphoma [Merck]

5.2.2 Pharma - Fusions & Acquisitions

AstraZeneca mulls £7bn move for prostate cancer drug company Medivation  [The Telegraph]

5.2.3 Pharma - économie

Roche reports solid sales growth in the first quarter of 2016 [Roche]

5.9 AACR

American Association for Cancer Research Inaugurates New Leadership at 2016 Annual Meeting [AACR]

Dr. Robert Weinberg Honored With AACR Award for Lifetime Achievement in Cancer Research [AACR]

5.9.1 AACR - sein

MammaPrint Genetic Test Can Reduce Use of Post-surgery Chemotherapy Among Early-stage Breast Cancer Patients [AACR]

​​Breast Cancer Risk Prediction Models Improved by Adding Multiple Biological Markers of Risk [AACR]

​​A Presurgery Combination Therapy May Improve Outcomes for Women With HER2-positive Breast Cancer [AACR]

Palbociclib Showed Antiproliferative Activity in Early-stage Breast Cancer [AACR] AACR - sein - radiothérapie

For this controversial breast abnormality, is radiation treatment needed? [STAT]

Genetics May Influence Risk for Breast Cancer After Chest Radiotherapy to Treat Childhood Cancer [AACR]

Delays in Radiation Therapy Increase Chance of Breast Tumor Development in Women Treated for Ductal Carcinoma in Situ [AACR]

5.9.3 AACR - mélanome

Skin cancer 'breakthrough': Deadly tumours destroyed by radical new therapy [The Telegraph]

Skin cancer: Pair of drugs 'eliminate 20% of tumours' [BBC News]

5.9.6 AACR - prostate

Physical Activity May Improve Prostate Cancer Prognosis [AACR]

5.9.7 AACR - divers

Comparison of Three Different PD-L1 Diagnostic Tests Shows a High Degree of Concordance [AACR]

Running from Cancer? [The Scientist]

5.9.8 AACR - Pharma

AstraZeneca Presents DNA Damage Response Science At The AACR 2016 Annual Meeting [TheStreet]

Halozyme Expands Oncology Pipeline With Two Compounds Designed For Activity In The Tumor Microenvironment [Halozyme]

6. Lutte contre les cancers

NCI opens online platform to submit ideas about research for Cancer Moonshot [National Cancer Institute]

Stigma keeps some cancer patients from getting palliative care [Reuters]